The combination of intratumor administration of OV-mOX40L/IL12 with intravenously infused ovalbumin (OVA)-specific OT-I T cells significantly inhibited tumor growth and prolonged the overall survival of mice compared with the adoptive transfer of OT-I T cells alone (Figures S14B and S14C), supporting the hypothesis that OV-OX40L/IL12 can enhance the activity of systemically administered TILs. This evidence concerns the gene TNFSF4 and neoplasm.